Creative Planning’s EPIRUS BIOPHARMACEUTICALS INC COM EPRS Stock Holding History

Creative Planning’s Portfolio EPRS Stock Details EPRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-433	Closed	–	–	4988
2016 Q2	$0	Sell	433 -2,001	-82%	-$3.21K	﹤0.01%	4787
2016 Q1	$7K	Buy	2,434 +2,001	+462%	+$5.62K	﹤0.01%	3462
2015 Q4	$1K	Hold	433	–	–	﹤0.01%	4374
2015 Q3	$2K	Buy	+433	New	+$2.54K	﹤0.01%	4053
2015 Q2	–	Sell	-433	Closed	-$4K	–	4258
2015 Q1	$4K	Buy	433 +258	+147%	+$2.07K	﹤0.01%	3711
2014 Q4	$1K	Sell	175 -340	-66%	-$1.78K	﹤0.01%	4114
2014 Q3	$4K	Buy	+515	New	+$4.45K	﹤0.01%	3475

Other funds holding EPRS

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Creative Planning's EPRS Position: Q3 2016 in Review

Creative Planning sold out of EPIRUS BIOPHARMACEUTICALS INC COM (EPRS) in Q3 2016, closing a stake of 433 shares.

Creative Planning first reported a position in EPRS in Q3 2014 and held it in 7 quarters. The position peaked at $7K in Q1 2016. 3 funds tracked by Wall St. Rank hold EPRS as of Q3 2016.

Creative Planning reported no remaining EPIRUS BIOPHARMACEUTICALS INC COM position as of Q3 2016 after selling out during the quarter.
Creative Planning sold 433 EPIRUS BIOPHARMACEUTICALS INC COM shares in Q3 2016.
Creative Planning first reported a position in EPIRUS BIOPHARMACEUTICALS INC COM in Q3 2014 and held it in 7 quarters.
Creative Planning's EPIRUS BIOPHARMACEUTICALS INC COM position peaked at $7K in Q1 2016.
3 funds tracked by Wall St. Rank held EPIRUS BIOPHARMACEUTICALS INC COM as of Q3 2016.

Based on Creative Planning's 13F filing for Q3 2016, filed 12 Oct 2016.